BioNTech

BioNTech

BioNTech is a German company that develops immunotherapies for the treatment of cancer and other diseases.

Primarily focused on developing individualized cancer therapy, BioNTech is a biotechnology company located in Mainz, Germany.

Approach

Their method revolves around several platforms in medicine; mRNA Therapeutics, engineered cell therapies, antibodies, and small molecule immunomodulators. Coupled with their approach to patient specific needs, they have seen success in providing unique treatments.

  1. Sequencing patient's tumor
  2. Mapping of mutations
  3. Bioinformatic algorithms
  4. Selection of neoepitopes
Pipeline
COVID-19

BNT162 is BioNTech’s mRNA vaccine program aimed at preventing COVID-19 infection. It is the first product candidate from Project Lightspeed and leverages BioNTech’s proprietary mRNA platforms for infectious diseases, its fully-owned GMP manufacturing infrastructure for mRNA vaccine production, and its global clinical development capabilities, drawing on BioNTech’s network of global collaborators. BioNTech is partnered with Pfizer for co-development and distribution of BNT162 and with Fosun Pharma on the vaccine development in China.

Timeline

November 25, 2020
BioNTech and Shanghai Fosun Pharmaceutical says they will launch a Phase II clinical trial of BioNTech's experimental COVID-19 vaccine in China.
November 12, 2020
Commission approves contract with BioNTech-Pfizer alliance to ensure access to a potential vaccine

The European Commission approved a fourth contract with pharmaceutical companies BioNTech and Pfizer, which provides for the initial purchase of 200 million doses on behalf of all EU Member States, plus an option to request up to a further 100 million doses, to be supplied once a vaccine has proven to be safe and effective against COVID-19. Member States can decide to donate the vaccine to lower and middle-income countries or to re-direct it to other European countries.

September 15, 2020
BioNTech raises a $455,600,000 grant.
June 29, 2020
BioNTech raises a $250,000,000 venture round from Temasek Holdings.
December 17, 2019
BioNTech raises a $60,747,000 venture round from European Investment Bank.
September 4, 2019
BioNTech raises a $55,000,000 grant from Bill & Melinda Gates Foundation.
July 9, 2019
BioNTech raises a $325,000,000 series B round from Fidelity Management & Research Company.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
BioNTech funding round, January 2018
270,000,000
January 2018
91,500,000
January 4, 2018
8 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Özlem Türeci

Chief Medical Officer

Ryan Richardson

Chief Strategy Officer

Sean Marett

Chief Business and Chief Commercial Officer

Sierk Poetting

Chief Financial Officer and Chief Operating Officer

Ugur Sahin

Chief Executive Officer

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

BioNTech Corporate Video

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Alex Keown
April 9, 2021
BioSpace
BioSpace takes a look at the annual compensation for the chief executive officers of vaccine developers.
Alex Keown
April 9, 2021
BioSpace
BioSpace takes a look at the annual compensation for the chief executive officers of vaccine developers.
Kelly McLaughlin
April 9, 2021
Business Insider
The vaccine showed "100 percent efficacy" and triggered a "robust antibody response" in trials with adolescents, the companies announced last month.
April 9, 2021
NDTV.com
With a strategic alliance, 24-hour production and a bit of luck, Pfizer and BioNTech were able to roll out their Covid vaccine at a brisk pace and relatively free of controversy.
Reuters Staff
April 6, 2021
news.yahoo.com
There is a link between AstraZeneca's COVID-19 vaccine and very rare blood clots in the brain but the possible causes are still unknown, a senior official...
Alexander Smith
April 1, 2021
NBC News
Pfizer and BioNTech said Thursday that trials suggest their vaccine is effective against the B.1.351 coronavirus variant that first emerged in South Africa.
Frank Jordans
March 19, 2021
Global News
As BioNTech's profile has grown during the pandemic, so has its value, providing funds the company can use to pursue its original goal of developing a new tool against cancer.
Sky
March 19, 2021
Sky News
The technology used to develop the Pfizer jab can be applied to get the immune system to take on tumours, says its co-creator.
Alison Rourke
March 16, 2021
the Guardian
A healthcare worker prepares a syringe with the AstraZeneca/Oxford Covid vaccine in Spain on Monday. Photograph: Gustavo Valiente/SOPA Images/REX/Shutterstock
Alison Rourke
March 16, 2021
the Guardian
A healthcare worker prepares a syringe with the AstraZeneca/Oxford Covid vaccine in Spain on Monday. Photograph: Gustavo Valiente/SOPA Images/REX/Shutterstock
Kanishk Tharoor
March 2, 2021
the Guardian
Not one Covid jab had been administered in 130 of the world's poorer countries by mid-February, says the editor, author and presenter Kanishk Tharoor
Darrell Etherington
February 19, 2021
TechCrunch
The COVID-19 vaccine developed by Pfizer and BioNTech now has less stringent and extreme transportation requirements than it debuted with. Originally, the mRNA-based vaccine had to be maintained at ultra-low temperatures throughout the transportation chain in order to remain viable - between -76°F and -112°F. New stability data collected by Pfizer and BioNTech, which has [...]
Reuters
February 17, 2021
the Guardian
Plan to buy the BioNTech shot has been delayed amid intervention by 'outside forces', says health minister
Beth Mole
February 5, 2021
Ars Technica
The regulatory agency is drawing on its experience with annually tweaked flu shots.
David Rotman
February 5, 2021
MIT Technology Review
New messenger RNA vaccines to fight the coronavirus are based on a technology that could transform medicine. Next up: sickle cell and HIV.
Grace Dean
February 2, 2021
Business Insider
Pfizer posted fourth-quarter revenues up 12% year-over-year, and said it expected to produce up to 2 billion doses its and BioNTech's vaccine in 2021.
Michael Le Page, Clare Wilson, Jessica Hamzelou, Sam Wong, Graham Lawton, Adam Vaughan, Conrad Quilty-Harper and Layal Liverpool
January 29, 2021
New Scientist
The latest coronavirus news updated every day including coronavirus cases, the latest news, features and interviews from New Scientist and essential information about the covid-19 pandemic
Michael Le Page, Clare Wilson, Jessica Hamzelou, Sam Wong, Graham Lawton, Adam Vaughan, Conrad Quilty-Harper and Layal Liverpool
January 28, 2021
New Scientist
The latest coronavirus news updated every day including coronavirus cases, the latest news, features and interviews from New Scientist and essential information about the covid-19 pandemic
Michael Le Page, Clare Wilson, Jessica Hamzelou, Sam Wong, Graham Lawton, Adam Vaughan, Conrad Quilty-Harper and Layal Liverpool
January 27, 2021
New Scientist
The latest coronavirus news updated every day including coronavirus cases, the latest news, features and interviews from New Scientist and essential information about the covid-19 pandemic
January 26, 2021
@FinancialTimes
Today's top news: CDC urges US schools to curb indoor sport to prevent outbreaks. Hong Kong extends dining and social distancing rules for another week. Colombia's defence minister becomes the country's highest-profile victim of the pandemic.
SHOW MORE

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.